Stocks and Investing
Stocks and Investing
Tue, April 18, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joseph Stringer Reiterated (CDTX) at Strong Buy and Held Target at $60 on, Apr 18th, 2023
Joseph Stringer of Needham, Reiterated "Cidara Therapeutics, Inc." (CDTX) at Strong Buy and Held Target at $60 on, Apr 18th, 2023.
Joseph has made no other calls on CDTX in the last 4 months.
There are 2 other peers that have a rating on CDTX. Out of the 2 peers that are also analyzing CDTX, 0 agree with Joseph's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Joseph
- Ed Arce of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $120 on, Friday, March 24th, 2023
- Louise Chen of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $100 on, Wednesday, March 8th, 2023
Contributing Sources